BridgeMD
Reduction of blood loss in pediatric surgical procedures around the hip - A trial with tranexamic acid
EU CTIS ID: 2024-516324-34-01
What this study is testing
To evaluate (reduction of) intraoperative blood-loss with and without pre-operative TXA administration, in children undergoing a proximal femoral and/or pelvic osteotomy (PFPO). Primary research question: Is pre-operative TXA administration associated with reduced intraoperative blood loss, compared to placebo, in children undergoing a proximal femoral and/or pelvic osteotomy for DDH or other indications?
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Proximal femoral and/or pelvic osteotomy/ies
- 1-18 years old
- Any indication for surgery
- Performed at our institution
You likely can't join if
- Contraindications for TXA
- Active use of alternative (anti)fibrinolytics
- Diagnosed bleeding or coagulation disorder
- Medical history of thromboembolic complications
- Use of hormonal contraception
- Insufficient Dutch language skills of the patient and/or caretakers
See the full eligibility criteria
- Proximal femoral and/or pelvic osteotomy/ies
- 1-18 years old
- Any indication for surgery
- Performed at our institution
- Contraindications for TXA
- Active use of alternative (anti)fibrinolytics
- Diagnosed bleeding or coagulation disorder
- Medical history of thromboembolic complications
- Use of hormonal contraception
- Insufficient Dutch language skills of the patient and/or caretakers
- No informed consent
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.